BioSpace News Archive

These products will be the first oral solid oncology products for Armas.

Strengthened portfolio delivers optimal control and better outcomes

Devonian is a clinical stage botanical pharmaceutical corporation focused on developing a unique portfolio of botanical prescription drugs and cosmeceutical products

Researchers at the National Institutes of Health (NIH) have shown that inhibition of myeloid-derived suppressor cell (MDSC) trafficking into mouse solid tumors by SX-682 enhanced both PD-1 immune checkpoint blockade (ICB) and T cell receptor (TCR) engineered T cell immunotherapy, leading to significant tumor growth inhibition or eradication.

Without the continued support of so many, St. Baldrick’s would not be here today as the largest private funder of childhood cancer research grants.

The Government of Canada is committed to providing national leadership to support the mental health of public safety personnel, by providing coordination, facilitating collaboration, sharing best practices and funding cutting-edge research.

Appili Therapeutics Inc. announced today that it will participate in the Bloom Burton & Co.

Validates clinical hypothesis on which the company’s technology was founded

Welsh, Carson, Anderson & Stowe announced today that Dan Mendelson, a highly-regarded executive in the healthcare industry, has joined the firm’s Healthcare team as an Operating Partner.

Derivatives with Higher-Margins Increasing Growth and Revenues